CEMEX, S.A.B. de C.V.
NYSE:CXConstruction Materials
+$0.15 today
- Market cap
- $14.23B
- Beta
- 0.83
- P/E (TTM)
- 41.2
- EPS (TTM)
- $0.03
- Dividend yield
- 0.73%
Volume 7.61M
Average 5.45M
CX EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
CEMEX, S.A.B. de C.V.NYSE: CX
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $934.74M rose 6.7% year over year, ahead of the +1.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 21.5% from the prior quarter. Over 3 fiscal years it compounded at +5.8% a year.
Context
- EBITDA amounted to 15.9% of revenue in FY2025, down 1.5 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 7 analysts of $1.97B (-23.6%) for the fiscal year ending Dec 2026, a slowdown from the -8.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $934.74M+21.5% QoQ
- Last fiscal yearDec 2025
- $2.57B-8.4% YoY
- LTMJun 2026
- $2.8B+1.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +6.7% | -39.4% | -46.1 pp |
| 1 year | -8.4% | -23.6% | -15.1 pp |
| 3-year CAGR | +5.8% | -8.5% | -14.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 2.57B USD
- Year-over-year change
- -8.4%
- 4-year CAGR
- -1.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.57B | -8.4% |
| FY2024 | 2024-12-31 | 2.81B | -8.5% |
| FY2023 | 2023-12-31 | 3.07B | +41.2% |
| FY2022 | 2022-12-31 | 2.18B | -18.9% |
| FY2021 | 2021-12-31 | 2.68B | — |
EBITDA vs competitors
How CX compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1.3% is the 3rd highest of 6, against a peer median of -5.0%.
- EBITDA amounts to 16.5% of revenue for CX, versus a peer median of 31.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | ARS 180.96B ARS | -39.0% | +0.8% | 21.8% | |
| LTM Jun 2026 | $8.82B USD | +23.6% | +11.4% | 22.8% | |
| LTM Jun 2026 | $2.8B USD | +1.3% | +5.8% | 16.5% | |
| LTM Jun 2026 | $2.56B USD | +19.5% | +19.0% | 31.5% | |
| LTM Jun 2026 | $2.08B USD | -5.0% | +7.0% | 31.2% | |
| LTM Jun 2026 | $741.67M USD | -5.3% | +0.1% | 31.9% | |
| Peer median (excluding CX) | — | -5.0% | +7.0% | 31.2% | |
Competitors are the stored peer set for CX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 14.38B | 14.71B | 16.4B | 16.06B | 16.13B |
| Cost of Revenue | 9.74B | 10.22B | 10.87B | 10.66B | 10.82B |
| Gross Profit | 4.64B | 4.49B | 5.54B | 5.41B | 5.31B |
| Gross Margin | 32.2% | 30.5% | 33.7% | 33.7% | 32.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.05B | 1.19B | 1.45B | 1.47B | 1.57B |
| Operating Expenses | 3B | 3.12B | 3.59B | 3.59B | 3.52B |
| Depreciation & Amortization | 1.12B | 1.07B | 1.17B | 1.23B | 1.29B |
| EBITDA | 2.68B | 2.18B | 3.07B | 2.81B | 2.57B |
| EBITDA Margin | 18.6% | 14.8% | 18.7% | 17.5% | 15.9% |
| Operating Income | 1.64B | 1.36B | 1.95B | 1.82B | 1.79B |
| Operating Margin | 11.4% | 9.3% | 11.9% | 11.3% | 11.1% |
| Interest Income | 22M | 27M | 37.31M | 18M | 15.95M |
| Interest Expense | 658M | 401M | 543.52M | 595M | 543.55M |
| Other Income / Expenses | (683M) | (791M) | (620M) | (832M) | (1B) |
| Income Before Tax | 954M | 570M | 1.33B | 991M | 789M |
| Pre-Tax Margin | 6.6% | 3.9% | 8.1% | 6.2% | 4.9% |
| Income Tax Expense | 137M | 168M | 1.21B | 67M | 385M |
| Net Income | 753M | 858M | 182M | 939M | 960M |
| Net Margin | 5.2% | 5.8% | 1.1% | 5.8% | 6.0% |
| EPS (Basic) | 0.51 | 0.59 | 0.12 | 0.61 | 6.60 |
| EPS (Diluted) | 0.50 | 0.58 | 0.12 | 0.61 | 6.60 |
| Weighted Avg Shares | 1.47B | 1.48B | 1.47B | 1.47B | 144.89M |
| Weighted Avg Shares (Diluted) | 1.5B | 1.48B | 1.47B | 1.47B | 144.89M |
CEMEX, S.A.B. de C.V.
NYSE:CX
Intrinsic Alpha fair value
Locked
Current Price
$9.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.